Chairs:
- Cora Lee Wetherington, Ph.D., Chair
Office of the Director
- Katherine Davenny, M.P.H. - HIV/AIDS & other infectious diseases; medical consequences; medical/prevention interventions; mother-infant transmission; cross-NIH collaborations
- Jose Ruiz, Ph.D. PMP - scientific training and career development, project management, science policy, tools for research program analyses/evaluations
Office of Science Policy and Communications (OSPC)
- Carol Krause, M.A. - public education and outreach; media; web content; social marketing
Center for the Clinical Trials Network (CCTN)
- Carmen L. Rosa, M.S. - clinical research/clinical trials; regulatory affairs; health disparities/ethnic populations; women's health; and criminal justice
- Betty Tai, Ph.D. - clinical pharmacology; clinical trials relevant to clinical practice
Division of Extramural Research (DER)
- Susan McGuire
- Ivan Navarro, Ph.D. - neurodegeneration, neurogenesis, clinical trials
- Michelle Rankin, Ph.D.
- Susan Weiss, Ph.D. - science policy and research; training
Division of Epidemiology, Services and Prevention Research (DESPR)
- Heather Kimmel, Ph.D. - epidemiology of drug use and disorder; interactions between policy and drug use; polysubstance use and outcomes; translational research in substance use and outcomes
- Dionne J. Jones, Ph.D. - interventions and treatment services for HIV/AIDS; gender differences; co-occurring disorders; ethnic populations (african american)
- Elizabeth Lambert, M.Sc. - natural history and epidemiology of HIV/AIDS among drug users; HIV/AIDS and drug abuse; clinical epidemiology and HIV disease
- Jacqueline Lloyd, Ph.D. - drug abuse prevention interventions; HIV prevention in at risk populations; peer and social network prevention interventions; role of family and peer factors on adolescent drug use
- Marsha Lopez, Ph.D. - epidemiology of drug use and disorder; comorbidity of drug and other psychiatric disorders; national studies examining the patterns of drug use and disorder across the life course; research training
- Karen Sirocco, Ph.D. - clinical neuropsychology; comorbid mental health disorders; consequences of youth drug use/abuse
Division of Neuroscience & Behavior (DNB)
- Beth Babecki, M.A. - training and career development
- Kris Bough, Ph.D. - smoking cessation treatment, clinical drug development, neuroscience
- Christie Espinoza
- Mary Kautz, Ph.D. - neuropsychopharmacology, human behavioral psychopharmacology, smoking
- Amy C. Lossie, Ph.D. - genetics, epigenetics, animal models of disease, somatic mutations
- Vani Pariyadath, Ph.D.
- Vishnudutt Purohit, DVM, Ph.D. - prenatal and perinatal exposure of drugs; HIV/AIDS and HCV basic research; cardiovascular and hepatotoxicity; oxidative stress, inflammation, and apoptosis; epithelial and endothelial barriers, including blood brain barrier
- Shelley Su, Ph.D. - negative affect, operant conditioning, cognition
- Cora Lee Wetherington, Ph.D. - basic behavioral laboratory research (animals and humans); prenatal drug exposure; sex/gender differences; vulnerability
Division of Therapeutics and Medical Consequences (DTMC)
- Will Aklin, Ph.D. - treatment development; research to test efficacy; theory-derived putative targets/mechanisms of behavior change; adherence; integration of behavioral and pharmacological treatments
- Jag H. Khalsa, Ph.D. - medical consequences of drugs of abuse and co-occurring infections including HIV, Hepatitis C, STDs, TB and others
- Philip Krieter, Ph.D. - ADME
Contact:
Any questions or concerns regarding the Women and Gender Research Group please contact Cora Lee Wetherington, Ph.D., (301) 435-1319.